Position in RLAY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$527,565
+$244,896 QoQ
Shares Held
28,197
-0.7% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#149
of 256 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RLAY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ProShare Advisors LLC holds $336,334,656 across 174 Biotechnology names. RLAY ranks #49 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
287,847 | $142,982,240 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
119,240 | $74,350,909 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
128,514 | $38,686,569 | |
| 4 | INCY |
Incyte Corp
|
48,152 | $5,458,510 | |
| 5 | MRNA |
Moderna, Inc.
|
70,621 | $4,945,588 | |
| 6 | CYTK |
Cytokinetics Inc
|
27,121 | $2,310,437 | |
| 7 | TECH |
BIO-TECHNE Corp
|
30,597 | $2,161,678 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
4,760 | $1,769,149 |
All Filings in RLAY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $527,565 | 28,197 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $282,669 | 28,409 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $282,487 | 33,391 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $150,210 | 28,776 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $116,107 | 33,557 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $91,390 | 34,882 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $173,864 | 42,200 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $189,092 | 26,708 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $136,157 | 20,883 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $217,576 | 26,214 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $251,248 | 22,820 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $165,786 | 19,713 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $246,314 | 19,611 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $303,591 | 18,433 | Shares | Sole | 2023-05-26 | |
| 2022-12-31 | $312,993 | 20,950 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $393,600 | 17,595 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $285,704 | 17,057 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $728,107 | 24,327 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $936,655 | 30,500 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $866,917 | 27,495 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,163,049 | 31,786 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $854,086 | 24,706 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $873,341 | 21,014 | Shares | Sole | 2021-02-09 | |
| No filing history on record for this holder in this stock. | ||||||